SKP2 siRNA inhibits the degradation of P27kip1 and down-regulates the expression of MRP in HL-60/A cells

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 8, 2009, Pages 699-708

  Xiao, Jie ^a   Yin, Songmei ^a   Li, Yiqing ^a   Xie, Shuangfeng ^a   Nie, Danian ^a   Ma, Liping ^a   Wang, Xiuju ^a   Wu, Yudan ^a   Feng, Jianhong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Leukemia; Multi drug resistance associated protein; RNA interference; S phase kinase associated protein 2

Indexed keywords

ANTINEOPLASTIC AGENT; CDKN1B PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN; SIGNAL PEPTIDE; SMALL INTERFERING RNA; UBIQUITIN;

ARTICLE; CELL CYCLE; CELL STRAIN HL 60; DOWN REGULATION; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HUMAN; METABOLISM;

ANTINEOPLASTIC AGENTS; CELL CYCLE; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; HL-60 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; UBIQUITIN;

EID: 68949111886     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp058     Document Type: Article

References (26)

1. Kim DH, Lee NY, Sung WJ, Baek JH, Kim JG, Sohn SK and Suh JS, et al. Multidrug resistance as a potential prognostic indicator in acute myeloid leukemia with normal karyotypes. Acta Haematol 2005, 114: 78-83.
2. Del Poeta G, Stasi R, Aronica G, Venditti A, Cox MC, Bruno A and Buccisano F, et al. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 1996, 87: 1997-2004.
3. Polyak K, Lee MH, Erdjument BH, Koff A, Roberts JM, Tempst P and Massagué J, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78: 59-66.
4. Sherr CJ and Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Gene 1999, 13: 1501-1512.
5. Qu Z, Weiss JN and Maclellan WR. Regulation of the mammalian cell cycle: a model of the G1-to-S transition. Am J Physiol Cell Physiol 2003, 284: C349-C364.
6. Andren EJ, Lledo E, Poch E, Ivorra C, Albero MP, Martínez-Climent JA and Montiel-Duarte C, et al. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res 2005, 65: 3264-3272.
7. Wang QH, Zhang M, Fang HH, Nie XX, Gao L, Liu Y and Xie Y, et al. Effect of adenovirus-mediated p27 gene expression on the proliferation and apoptosis of HL-60 and Raji cell lines. Hematol J 2004, 5: 519-523.
8. Seo YJ, Jeon MH, Lee JH, Lee YJ, Youn HJ, Ko JH and Lee JH, et al. Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27. Exp Mol Med 2005, 37: 624-630.
9. Munoz-Alonso MJ, Acosta JC, Richard C, Delgado MD, Sedivy J and León J. p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem 2005, 280: 18120-18129.
10. Barata JT, Cardoso AA, Nadler LM and Boussiotis VA. Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27kip1. Blood 2001, 98: 1524-1531.
11. Mi Y, Xue Y, Yu W, Liu S, Zhao Y, Meng Q and Bian S, et al. Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype. Leuk Lymphoma 2008, 49: 524-530.
12. Koistinen P, Räty R, Itälä M, Jantunen E, Koivunen E, Nousiainen T and Pelliniemi TT, et al. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group. Eur J Haematol 2007, 78: 477-486.
13. Schulman BA, Carrano AC, Jeffrey PD, Bowen Z, Kinnucan ER, Finnin MS and Elledge SJ, et al. Insights into SCF ubiquin ligases from the structure of the skp1-skp2 complex. Nature 2000, 408: 381-386.
14. Bornstein G, Bloom J, Sitry-Shevah D, Nakayama K, Pagano M and Hershko A. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21-Cip1 in S phase. J Biol Chem 2003, 278: 25752-25757.
15. Wang YY, Yang Y, Chen QY, Yu JP, Hou YZ, Han LZ and He J, et al. Simultaneous knockdown of p18INK4C, p27Kip1 and MAD1 via RNA interference results in the expansion of long-term cultureinitiating cells of murine bone marrow cells in vitro. Acta Biochim Biophys Sin 2008, 40: 711-720.
16. Yokozawa T, Towatari M, Iida H, Takeyama K, Tanimoto M, Kiyoi H and Motoji T, et al. Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia. Leukemia 2000, 14: 28-33.
17. Min YH, Cheong JW, Lee MH, Kim JY, Lee ST, Hahn JS and Ko YW, et al. Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia: its association with constitutive phosphorylation. Clin Cancer Res 2004, 10: 5123-5130.
18. Wada H, Saikawa Y, Niida Y, Nishimura R, Noguchi T, Matsukawa H and Ichihara T, et al. Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells. Exp Hematol 1999, 27: 99-109.
19. Kataqiri Y, Hozumi Y and Kondo S. Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. J Dermatol Sci 2006, 42: 215-224.
20. Agarwal A, Bumm TG, Corbin AS, O'Hare T, Loriaux M, VanDyke J and Willis SG, et al. Absence of SKP2 expression attenuates BCRABL- induced myeloproliferative disease. Blood 2008, 112: 1960-1970.
21. Xu M and Li J. Development of drug resistance and alteration of cell cycle in lung cancer: a flow cytometric study. Zhonghua Zhong Liu Za Zhi 2000, 22: 385-388.
22. Fu Y, Wang LY, Liang YL, Jin JW, Fang ZY and Zha XL. Integrin 1A up-regulates p27 protein amount at the post-translational level in human hepatocellular carcinoma cell line SMMC-7721. Acta Biochim Biophys Sin 2006, 38: 523-530.
23. Radosevic N, Delmer A, Tang R, Marie JP and Ajchenbaum-Cymbalista F. Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure. Leukemia 2001, 15: 559-566.
24. Sengupta A, Banerjee D, Chandra S and Banerjee S. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector. J Gene Med 2006, 8: 1251-1261.
25. Yang Q, Sakurai T, Yoshimura G, Takashi Y, Suzuma T, Tamaki T and Umemura T, et al. Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C. Anticancer Res 2000, 20: 4319-4322.
26. Ishii T, Matsuse T, Masuda M and Teramoto S. The effects of S-phase kinase-associated protein 2 (SKP2) on cell cycle status, viability, and chemoresistance in A549 lung adenocarcinoma cells. Exp Lung Res 2004, 30: 687-703.